Crinetics Pharmaceuticals Inc Net Asset Quality Index
Crinetics Pharmaceuticals Inc net asset quality index. Crinetics Pharmaceuticals Inc (CRNX) has a Net Asset Quality Index of 90.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.32 Billion minus total liabilities of $129.92 Million yields net assets of $1.19 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See CRNX net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Crinetics Pharmaceuticals Inc (2016–2025)
Net asset quality index of Crinetics Pharmaceuticals Inc from 2016 to 2025. This chart shows how Crinetics Pharmaceuticals Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at 90.2%, representing net assets of $1.19 Billion against total assets of $1.32 Billion USD. Check CRNX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Crinetics Pharmaceuticals Inc Net Asset Quality Index by Year (2016–2025)
Crinetics Pharmaceuticals Inc net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Crinetics Pharmaceuticals Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Crinetics Pharmaceuticals Inc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.4% | $992.08 Million | $1.14 Billion | $143.41 Million | ▼ -5.0 pp |
| 2024 | 92.3% | $1.32 Billion | $1.43 Billion | $109.79 Million | ▲ +7.5 pp |
| 2023 | 84.9% | $539.11 Million | $635.35 Million | $96.25 Million | ▼ -5.0 pp |
| 2022 | 89.8% | $316.33 Million | $352.18 Million | $35.85 Million | ▼ -4.7 pp |
| 2021 | 94.6% | $331.94 Million | $351.01 Million | $19.07 Million | ▲ +2.5 pp |
| 2020 | 92.1% | $168.92 Million | $183.44 Million | $14.53 Million | ▲ +2.2 pp |
| 2019 | 89.8% | $117.14 Million | $130.38 Million | $13.24 Million | ▼ -3.6 pp |
| 2018 | 93.5% | $160.22 Million | $171.41 Million | $11.19 Million | ▲ +189.8 pp |
| 2017 | -96.3% | $-15.02 Million | $15.60 Million | $30.62 Million | ▼ -47.1 pp |
| 2016 | -49.2% | $-6.20 Million | $12.60 Million | $18.80 Million | — |